Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks Clinical research trials and Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks. Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks clinical trial. Test subjects typically obtain the finest healthcare available for their Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks



Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

For Condition: Cardiovascular Diseases
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) , National Heart, Lung, and Blood Institute (NHLBI),National Institute on Aging (NIA)
Synopsis: The purpose of this study is to compare an herbal supplement, nonfood-derived vitamins, and placebo for the care of cardiovascular disease in high risk older African Americans.
Details: Older African Americans suffer from disproportionately high rates of cardiovascular disease (CVD) morbidity and mortality. In response to the health disparity between older African Americans and whites, national mandates have called for new research on innovative approaches to CVD prevention in this high risk population. Oxidative stress has recently been implicated in the pathogenesis of atherosclerotic CVD. Available evidence from epidemiological studies, clinical trials, and laboratory mechanistic studies indicate that antioxidant interventions may be useful in the prevention and treatment of atherosclerotic CVD in high risk older populations. Furthermore, it has been hypothesized that dietary or food sources of antioxidant nutrients may be more clinically effective than conventional nonfood-derived vitamin supplementation. Surveys indicate relatively high rates of complementary and alternative medicine (CAM) use, including herbal medicines, in older African Americans. Yet, with the exception of the previous clinical trials of the present Center team, there have been few controlled studies on CAM therapies in older African Americans and no previous controlled studies on efficacy and mechanisms of herbal antioxidants for the prevention of CVD in this high risk population. Preliminary studies have found that a CAM herbal preparation (MAK) derived from traditional Vedic medicine demonstrates potent antioxidant and anti-atherogenic effects in laboratory and pilot human studies. This study will evaluate the effects of this traditional CAM herbal preparation in older African Americans. This will be a controlled clinical trial at field site, Howard University Medical Center in Washington, DC, involving 138 older African American men and women (55 years of age and older) with documented atherosclerotic CVD who will be randomized to supplementation with either the traditional CAM herbal preparation (MAK 4+5), conventional vitamin cocktail (E+C) or placebo for 12 months. Clinical and mechanistic outcomes include carotid artery atherosclerosis (IMT), endothelial dysfunction (brachial artery reactivity), oxidized LDL, traditional CVD risk factors (BP, lipids, diet, exercise, smoking, weight) and quality of life. Participants will continue usual care. The results of this clinical study will provide much needed understanding of the basic and clinical effects of a traditional herbal antioxidant preparation on pathophysiological mechanisms of atherosclerotic CVD in this high risk group. This will facilitate translation of research findings on CAM into clinical practice for prevention of disease in this underserved and understudied population of high risk older African Americans.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized
Minimum Age/Maximum Age: 60 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - African American (self-identified) - Atherosclerotic coronary heart disease (CHD)defined by documented clinical history of myocardial infarction, coronary revascularization procedure (CABG, PTCA), or coronary angiography demonstrating at least one coronary artery with >50% stenosis - High risk for CVD, defined as >=2 on Framingham/ATP III risk factor scale - Informed consent - Written permission of participant's referring physician
Total Enrollment: 138

Location and Contact Information:

Overall Study Official:
RobertSchneider,  Principal Investigator,  Center for Health and Aging Studies

Howard University Medical Center
Washington D.C.,  District of Columbia, 
United States
 

Maharishi University of Management
Fairfield,  Iowa,  52557
United States
 


Additional Information:
Study ID Numbers:
  1 P50 AT00082-01P3;  1-P50AT00082-01,5-P50AT00082-02
Study Start Date: 
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00010725

Other Cardiovascular Diseases Studies:
1. Honolulu Heart Program

2. Congestive Heart Failure Trends in the Elderly 1970-94

3. Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

4. Suppressed Anger, Blood Pressure and Mortality Follow-up

5. Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)

Related Studies:

Other Cardiovascular Diseases Clinical Trials
Other Iowa Clinical Trials
Other Fairfield Clinical Trials

Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks

Modify your Search

  Other Cardiovascular Diseases Clinical Trials
  Other Iowa Clinical Trials
  Other Fairfield Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103